Chemical Agents Sample Clauses

Chemical Agents. The improper discharge of a chemical agent (e.g., xxxx, pepper spray) in or around University Housing facilities is prohibited.
Sample 1Sample 2Sample 3See All (14)
AutoNDA by SimpleDocs
Chemical Agents. Identify all chemicals used at the property, including name, quantity(ies) used, maximum volume of storage containers, etc., OR refer to a chemical inventory to be included in an Appendix to this Plan.
Sample 1Sample 2Sample 3See All (5)
Chemical Agents. A. Chemical agents are compounds that may produce damaging or lethal effects. B. The potential of the agent to do damage is measured by how readily it disperses. Wind and rain will increase the dispersion rate of a chemical agent. i. Persistent agents have low volatility, evaporate slowly and are particularly hazardous in liquid form. They stay around for long periods of time (24 hours or longer) and contaminate not only the air but objects and terrain as well. Xxxxxxx and the nerve agent VX are examples of persistent agents. ii. Non-persistent agents are volatile and evaporate quickly, within several hours. Gases, aerosols, and highly volatile liquids tend to disperse rapidly after release. Phosgene, cyanide and the G series of nerve agents (with the exception of GD-Soman) are non-persistent agents. Because of their volatility, they pose an immediate respiratory hazard but are not particularly hazardous in liquid form. C. Chemical agents are classified by their effects: i. Nerve agents, the most deadly of all chemical agents, disrupt nerve transmission within organs and are quickly fatal in cases of severe exposure. ii. Blood agents (cyanides) interfere with the blood's ability to transport oxygen throughout the body; often rapidly fatal. iii. Blister agents, or vesicants, cause a blistering of the skin and mucous membranes, especially the lungs. iv. Choking agents, or pulmonary agents, irritate the lungs, causing them to fill with fluid. v. Incapacitating agents, cause an intense (but temporary) irritation of eyes and respiratory tract.
Sample 1Sample 2
Chemical Agents. The psychological, physiological, and toxicological effects of certain chemicals on the human body have been well-documented, and behavioral changes and mental disturbances resulting from chemical exposure that could lead to violence in workplace have been noted for many chemicals used in a wide variety of workplaces (Xxxxxxxx, 1996). Workplace exposure to metals and organic solvents is known to modify behaviors and increase excitability and irritation (Xxxxxxxx 1996). Metals that are commonly found in industrial settings and hazardous waste sites include mercury, lead, manganese, and tin. Of these metals, mercury and lead are the most commonly present at construction sites and environmental remediation sites in concentrations high enough to cause toxicity in adults. Exposure to high levels of mercury causes the condition known as erethism, which is typified by antisocial behavior and emotional outbursts. Author Xxxxx Xxxxxxx illustrated this bizarre behavior with his character The Mad Hatter in Xxxxx’s Adventures in Wonderland (Xxxxxxx 2010). However, in construction and remediation settings, mercury toxicity is relatively uncommon, due to the chemical‘s heavy molecular weight, low boiling point, and low vapor pressure, which makes airborne exposure unlikely (Xxxxxxxx, 1997). Lead is more common and pervasive at construction and remediation sites, commonly found in the form of dust. The dust is inhaled by workers and overexposure to lead in adults can cause irritability, anxiety, and sleep disorders. Often these symptoms are present in the absence of other physical symptoms such as anemia, peripheral neuropathies, wrist drop, and lead lines in the gums. In some cases, the mental and behavioral symptoms are present but the lead toxicity goes undiagnosed because of the lack of physical symptoms (Xxxxxxx, 2009). Manganese and tin cause toxic responses similar to that of lead, but they are not frequently encountered in the construction or remediation industries. Other metals such as arsenic, thallium, bismuth and zinc, which are often found at hazardous waste sites, will display systemic pathologies prior to behavioral changes (Xxxxxxxx, 1997). Organic solvents typically present behavioral changes in acute dosages and exposure scenarios. The mechanism by which solvents reach the brain via their ability to cross the blood/brain barrier is well-known. Epidemiological studies linking chronic exposures of organic solvents with antisocial behaviors have been repor...
Sample 1

Related to Chemical Agents

  • Chemical Substances Supplier warrants that: (i) each chemical substance contained in Products is on the inventory of chemical substances compiled and published by the Environmental Protection Agency pursuant to the Toxic Substances Control Act and (ii) all Material Safety Data Sheets required to be provided by Supplier for Products shall be provided to DXC prior to shipment of the Products and shall be complete and accurate.

  • Pharmacovigilance Licensee shall maintain until the termination of this Agreement (or, as applicable, until the rights and obligations intended to survive termination of this Agreement have been fulfilled) pharmacovigilance and risk management systems, procedures and documentation needed to perform and comply with its regulatory obligations and its related obligations under this Agreement. Licensee shall ensure that it will comply with all Applicable Law regarding Licensed Product in the Territory, including, without limitation, those laws and regulations relating to risk management, drug safety and pharmacovigilance. If Licensee becomes aware of any adverse reaction relating to Licenced Product in connection with this Agreement, Licensee shall inform MPP and Pfizer within twenty-four (24) hours of its becoming aware and cooperate with Pfizer in fulfilling Pfizer’s reporting responsibilities under Applicable Law. Licensee will be responsible for fulfilling all pharmacovigilance activities pursuant to the local regulations and requirements for the Licenced Products in the Territory and provide MPP and Pfizer with a report containing information regarding all such activities. Such report shall be provided annually, on February 1 of each year, and otherwise on reasonable request by MPP or Pfizer to both MPP and Pfizer’s pharmacovigilance contact as may be designated by Pfizer from time to time. Licensee shall notify MPP and Pfizer forthwith of the receipt of an enquiry from an Agency in the Territory relating to Licensed Product that concerns any safety issue. If Licensee becomes aware of any action that may be, will be or has been taken by an Agency for a safety reason connected with Licensed Product, it shall immediately, and in any event no later than twenty-four

  • Organ Transplants This plan covers organ and tissue transplants when ordered by a physician, is medically necessary, and is not an experimental or investigational procedure. Examples of covered transplant services include but are not limited to: heart, heart-lung, lung, liver, small intestine, pancreas, kidney, cornea, small bowel, and bone marrow. Allogenic bone marrow transplant covered healthcare services include medical and surgical services for the matching participant donor and the recipient. However, Human Leukocyte Antigen testing is covered as indicated in the Summary of Medical Benefits. For details see Human Leukocyte Antigen Testing section. This plan covers high dose chemotherapy and radiation services related to autologous bone marrow transplantation to the extent required under R.I. Law § 27-20-60. See Experimental or Investigational Services in Section 3 for additional information. To speak to a representative in our Case Management Department please call 1-401- 000-0000 or 1-888-727-2300 ext. 2273. The national transplant network program is called the Blue Distinction Centers for Transplants. SM For more information about the Blue Distinction Centers for TransplantsSM call our Customer Service Department or visit our website. When the recipient is a covered member under this plan, the following services are also covered: • obtaining donated organs (including removal from a cadaver); • donor medical and surgical expenses related to obtaining the organ that are integral to the harvesting or directly related to the donation and limited to treatment occurring during the same stay as the harvesting and treatment received during standard post- operative care; and • transportation of the organ from donor to the recipient. The amount you pay for transplant services, for the recipient and eligible donor, is based on the type of service.

  • Infectious Diseases The Employer and the Union desire to arrest the spread of infectious diseases in the nursing home. To achieve this objective, the Joint Health and Safety Committee may review and offer input into infection control programs and protocols including surveillance, outbreak control, isolation, precautions, worker education and training, and personal protective equipment. The Employer will provide training and ongoing education in communicable disease recognition, use of personal protective equipment, decontamination of equipment, and disposal of hazardous waste.

  • Musculoskeletal Injury Prevention and Control The hospital in consultation with the Joint Health and Safety Committee (JHSC) shall develop, establish and put into effect, musculoskeletal prevention and control measures, procedures, practices and training for the health and safety of employees.

  • Manufacturing (a) The Supplier shall without limitation be responsible, at no additional cost to the Purchaser, for: sourcing and procuring all raw materials for the Products; obtaining all necessary approvals, permits and licenses for the manufacturing of the Products; providing sufficient qualified staff and workers to perform the obligations under this Purchase Agreement; implementing and maintaining effective inventory and production control procedures with respect to the Products; and handling other matters as reasonably requested by the Purchaser from time to time. (b) The Supplier shall not change any process, material, component, packaging or manufacturing location without the Purchaser’s express prior written approval.

  • Controlled Substances The use or possession of any controlled substance will result in immediate cancellation of the use agreement.

  • Anti-slavery and human trafficking The Supplier shall: ensure that slavery and human trafficking is not taking place in any part of its business or in any part of its supply chain; implement due diligence procedures for its own suppliers, subcontractors and other participants in its supply chains, to ensure that there is no slavery or human trafficking in its supply chains; respond promptly to all slavery and human trafficking due diligence questionnaires issued to it by the British Council from time to time and ensure that its responses to all such questionnaires are complete and accurate; and notify the British Council as soon as it becomes aware of any actual or suspected slavery or human trafficking in any part of its business or in a supply chain which has a connection with this Agreement. If the Supplier fails to comply with any of its obligations under clause 13.1, without prejudice to any other rights or remedies which the British Council may have, the British Council shall be entitled to: terminate this Agreement without liability to the Supplier immediately on giving notice to the Supplier; and/or reduce, withhold or claim a repayment (in full or in part) of the charges payable under this Agreement; and/or share with third parties information about such non-compliance.

  • Samples The Contractor shall submit the following samples of Materials and relevant information to the Authority’s Engineer for pre-construction review: (a) manufacturer's test reports and standard samples of manufactured Materials; and (b) samples of such other Materials as the Authority’s Engineer may require.

  • Vaccination and Inoculation ‌ (a) The Employer agrees to take all reasonable precautions to limit the spread of infectious diseases among employees, including in-service seminars for employees. Where the Employer or Occupational Health and Safety Committee identifies high risk areas which expose employees to infectious or communicable diseases for which there are protective immunizations available, such immunizations shall be provided at no cost to the employee. The Committee may consult with the Medical Health Officer. Where the Medical Health Officer identifies such a risk, the immunization shall also be provided at no cost. The Employer shall provide Hepatitis B vaccine, free of charge, to those employees who may be exposed to bodily fluids or other sources of infection. (b) An employee may be required by the Employer, at the request of and at the expense of the Employer, to take a medical examination by a physician of the employee's choice. Employees may be required to take skin tests, x-ray examination, vaccination, and other immunization (with the exception of a rubella vaccination when the employee is of the opinion that a pregnancy is possible), unless the employee's physician has advised in writing that such a procedure may have an adverse effect on the employee's health.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!